SCRI/LinkedIn
May 17, 2025, 08:12
Sarah Cannon Research Institute Announced a Strategic Collaboration with IQVIA to Enhance Oncology Clinical Trials Globally
Sarah Cannon Research Institute shared a post on LinkedIn:
“We’re excited to announce a strategic collaboration between Sarah Cannon Research Institute’s contract research organization, SCRI Development Innovations, and IQVIA to enhance oncology clinical trials globally.
By combining SCRI’s community-based expertise and Accelero model with IQVIA’s global scale and data capabilities, we can transform clinical trial delivery with sponsors and ultimately bring cutting-edge therapies to patients faster.
Meet us at ASCO 2025 in Chicago to learn more about this exciting collaboration.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 17:21
Aug 8, 2025, 17:21
Aug 8, 2025, 16:46
Aug 8, 2025, 16:41
Aug 8, 2025, 16:31
Aug 8, 2025, 16:11
Aug 8, 2025, 15:57
Aug 8, 2025, 15:54
Aug 8, 2025, 15:49